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Abstract
Obesity, hypertension, and diabetes have risen dramatically in Asia, but few cohort studies track 
age and secular trends in these conditions. We use Cebu (Philippines) Longitudinal Health and 
Nutrition survey data to document 1998–2015 prevalence and co-occurrence of BMI>25 kg/m2, 
high waist circumference (WC>80 cm), elevated blood pressure (EBP, systolic >=130 or 
diastolic>=85 mm Hg), and type 2 diabetes among ~2000 women ages 29–62 1998; and identify 
their relationship to community, household, and individual factors using longitudinal logistic 
regression. Prevalence (1998–2015) rates were: 35–49%, BMI>25 kg/m2; 32–58% high WC; 21–
59% EBP; 2–14% diabetes. Only 20% of women had none of these conditions in 2015. Diabetes 
was strongly driven by age and secular trends in high WC related to higher SES and urbanization. 
Hypertension increased with age in lower SES rural, and more affluent urban women. Results 
underscore the continuing need for public health measures to prevent obesity and to identify and 
treat hypertension and diabetes.
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Introduction
Obesity, type 2 diabetes, and hypertension are increasing rapidly in many low- and middle-
income countries, and cardio-metabolic (CM) diseases have become the top causes of 
mortality.[1–5] While obesity, and in particular central obesity, is a well-established risk 
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factor for type 2 diabetes and hypertension, some studies suggest that there is a 
“metabolically healthy-obese” phenotype characterized by a BMI > 25 kg/m2 (or >23 kg/m2 
in some Asian populations), without type 2 diabetes, hypertension, or dyslipidemia.[6–8] A 
distinct pattern of fat distribution may characterize this phenotype, particularly in Asians,[9] 
with metabolically healthy obese individuals having less central adiposity.[9, 10] However, 
this phenotype may be only a phase in the development of CM disease risk, as many 
metabolically healthy obese individuals subsequently develop CM disease as they age. 
[11–14]
There are few long term longitudinal studies in Asian populations where CM diseases 
develop at a lower BMI and at younger ages than in European or African populations.[15] We 
present analyses from the Cebu Longitudinal Health and Nutrition Survey (CLHNS)[16], 
which has followed a cohort of Filipino women since 1983, but added an emphasis on non-
communicable disease risk in 1998. Our main objectives were to (1) describe 17-year trends 
in the prevalence and co-occurrence of BMI>25 kg/m2 (OWOB), high waist circumference 
(WC), elevated blood pressure (EBP) and type 2 diabetes (referred to as diabetes, hereafter) 
and (2) determine how community, household and individual sociodemographic factors 
relate to phenotypes characterized by co-occurrence of these conditions over time.
Methods
Study sample and data.
In 1983, single-stage cluster-sampling was used to randomly select 17 urban and 16 rural 
barangays (administrative units) of Metro Cebu, the second largest metropolitan area in the 
Philippines.[16] All pregnant women in these barangays were invited to join the study, 
forming a one-year birth cohort. We use data from 1998–2015 surveys which included 
measurement of CM disease risk factors: 1998–99 (N=1989), 2002 (N=2,102), 2005 
(N=2,018), 2007 (N=1,977) 2012 (N=1,815) and 2015 (N=1568).
Individual, household, and community data.
CLHNS data were collected during in-home interviews, supplemented with assessments in 
clinical settings by nurses or medical technologists. Socioeconomic (SES) and demographic 
information included age, education, household income and assets, and urbanicity of 
residence. We categorized age in 1998 as <35 yr, 35–39, 40–44, 45–50, and 50+ years. SES 
was represented by wealth (a factor score reflecting ownership of 31 household assets), 
household income (log-transformed earnings of all household members), and maternal years 
of schooling. A multi-component urbanicity index represented population size and density, 
community infrastructure, and economic and environmental characteristics of each barangay.
[17] Weight, height, and waist circumference (WC) were measured using standard 
techniques. In 2012 and 2015, we used Tanita© scales, which estimate total body fat based 
on bioelectric impedence (BIA), and provide a visceral fat score based on BIA, age, and 
anthropometrics. Overweight-obese weight status was categorized as BMI>25 kg/m2. 
Despite suggestions of elevated CM risk at lower BMI among Asians,[18, 19] we used this 
cut-point for greater comparability with other studies. High WC was defined as >80 cm.
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Blood pressure was measured in triplicate by trained research staff or medical technologists 
using appropriate cuff sizes, after a 10-minute seated rest, using mercury 
sphygmomanometers (1998–2007) or OMRON HEM-7211 blood pressure monitors (2012–
2015). We defined EBP as systolic blood pressure >130 or diastolic blood pressure>85 mm 
Hg, or taking anti-hypertensive medications [International Diabetes Foundation (IDF) 
guidelines].[20] We used this cutpoint because it is part of the IDF guidelines for the 
definition of multiple risk factors associated with the development of cardiometabolic 
diseases. Medications were reported and verified as anti-hypertensives.
Diabetes was self-reported in 1998 and 2002. In 2005, we collected fasting venous blood 
and defined diabetes as glucose≥7.0 mmol/L. In 2012 and 2015, we defined diabetes as 
HbA1c>6.5% (NycoCard Reader II). Fasting plasma lipids were measured only in 2005. 
Non-fasting lipids were measured in 2012 using the Cardiocheck point of care system. 
Because we only had 2 non-equivalent measures of lipids, and no self-reported dyslipidemia, 
lipids are not used to characterize time-varying phenotypes.
From reproductive histories updated at each survey, we identified total prior pregnancies in 
1998, and number of pregnancies in each subsequent survey interval. Women pregnant at the 
time of data collection were excluded only from that survey. Two-day mean intake of total 
energy and percentage of energy from fat, carbohydrate, and protein were estimated from 
24-hour dietary recalls, with nutrient values calculated using the Philippines food 
composition table.[21]
All participants provided informed consent, and the CLHNS has ongoing approval from 
Institutional Review Committees at the University of North Carolina, Chapel Hill, and the 
University of San Carlos in Cebu, Philippines.
Data analysis.
Graphical representations of prevalence over time in 5 age cohorts illustrate age and secular 
trends, and random effects longitudinal logistic regression (XTLOGIT in Stata 14)[22] was 
used to model predictors of having each condition. We then created individual phenotypes 
based on the presence or absence of conditions at each survey. Of 16 unique phenotypes, two 
(OWOB+diabetes, and OWOB+EBP+diabetes) found in only 1 or 2 individuals in any year 
were dropped from further analysis. For simplicity when naming phenotypes, hereafter 
“healthy” refers to the absence of EBP and diabetes. We estimated subsequent prevalence of 
EBP and diabetes among women who were healthy in 1998.
We used polytomous logistic regression models (MLOGIT in Stata 14)[22] to identify 
predictors of phenotypes across all years, clustering by participant ID to adjust standard 
errors for within-woman correlation of repeated measures. Models were first estimated with 
normal weight, low WC, healthy women as the referent, then with healthy OWOB women 
with high WC (the second most frequent phenotype) as the referent. Covariates included 
age, height, household assets, income, education, urbanicity index, pregnancies, total energy 
intake, and percentage of energy from fat and carbohydrates, as recommended for an energy 
density model.[23] To gain further insight about the phenotypes, we compared mean total 
body fat and visceral fat score, CRP as a biomarker of inflammation, and total cholesterol to 
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HDL ratio as a marker of dyslipidemia in 2012 when these more detailed measures were 
available.
Results
Characteristics of women in each survey year are presented in Supplemental Table 1. 
Attrition and item non-response reduced the sample over time. In 1998, owing to a funding 
focus on CLHNS birth cohort offspring, women not residing with their index child were 
excluded. In subsequent years, all original CLHNS mothers were invited to participate. From 
1998 to 2015, the cumulative losses to follow-up are attributable to deaths (13.7%) 
migration from the study area (74.5%), refusals (4.0%) and ineligibility (7.8%). (See 
Perez[24] and Adair et al. [25] for a complete account of attrition in the CLHNS). The 
analysis sample for the current study included 2,184 women with a mean of 4.5 observations 
each. Missing data were more frequent among younger women in 1998 and 2002 (largely 
owing to pregnancy), and among urban women in later years. Women were 29–62 years old 
in 1998.
Age and secular trends in the prevalence of OWOB, high WC, EBP, and diabetes, and 
underlying sociodemographic factors associated with their prevalence across survey 
years.
OWOB, high WC, EBP, and diabetes increased markedly across survey years, but patterns 
differed substantially by age (Figure 1). The largest increases in OWOB and high WC were 
in the youngest groups, where prevalence of high WC nearly doubled. The secular trend can 
be appreciated by comparing the age group with mean age of 50 in 2002 to the age group 
with mean age of 50 in 2015. The 13-year secular increase is from 41% to 61% for OWOB 
prevalence, with a 4.6 kg increase in body weight; and from 47% to 65% for high WC 
prevalence with a 5.6 cm increase in WC.
Large increases in EBP prevalence occurred in all age groups. The prevalence difference 
related to the secular trend (as defined above) was 15 percentage points, corresponding to a 
12 mm Hg secular increase in SBP, not accounting for blood pressure medication use. 
Diabetes trends are shown only for the years when the definition was based on biomarkers 
(2005–2015). The prevalence difference related to the 10-year secular trend was 7.3 
percentage points.
Supplemental Table 2 presents logistic regression results with data pooled across years for 
each condition. Controlling for year, odds of EBP and diabetes increased markedly with age. 
Age-trends in OWOB and high WC leveled off with increasing age. Higher income was 
associated with increased odds of high WC, while higher assets were strongly associated 
with increased odds of OWOB, high WC, diabetes and EBP. Higher urbanicity and maternal 
education were associated with higher odds of OWOB, high WC, and diabetes.
Pattern of co-occurrence of OWOB, high WC, EBP, and diabetes over time.
In 1998, half of sample women were normal weight, low WC, and healthy, and 27% were 
OWOB and/or had high WC, but healthy (Figure 2). By 2015, only 20% had none of the 4 
conditions, and 17% were OWOB and/or had high WC, but healthy. Incident EBP accounted 
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for many changes in phenotype distribution over time. In 2015, the most prevalent 
phenotype was OWOB+high WC+EBP. Hypertension in the absence of OWOB or high WC 
became the third most prevalent phenotype in 2015. Among women without EBP in 1998, 
subsequent prevalence of EBP was strongly related to their weight and WC status 
(supplemental figure 1). Among women without diabetes in 2005, diabetes in 2012 and 2015 
was most strongly related to high WC. Among OWOB women without high WC, there was 
no diabetes.
Individual, household and community characteristics related to the phenotypes.
Phenotype-specific mean characteristics in 2012 are shown in Table 1. Compared to normal 
weight+low WC+healthy women (table 3, first row), women with EBP only were, on 
average, 2 years older. Women with high WC only, and women with high WC+EBP
+diabetes had higher CRP. WC and visceral fat score differentiated the phenotypes, even 
when WC was <80 cm. Among normal weight women, those with EBP had a higher visceral 
fat score, and those with diabetes had higher WC and visceral fat score compared to healthy 
women.
Compared to normal weight+low WC+healthy women, those with high WC and those with 
EBP and/or diabetes had higher BMI, and total and visceral fat. Among OWOB women, all 
with high WC had higher CRP. High atherogenic ratio (total cholesterol/HDL > 5), was 
more prevalent in women with any phenotype that included high WC, regardless of weight 
status, compared to women with low WC (47.3% vs 32.5%, respectively, Chi-squared 
P<0.001).
The first set of multinomial logistic regressions estimated the likelihood of being in each 
phenotype relative to normal weight+low WC+healthy women (Supplemental table 3). 
Regardless of weight status, older age was associated with higher likelihood of all 
phenotypes that included diabetes or EBP, with the largest age effects in women over 40 in 
1998. Taller stature was associated with higher likelihood of all phenotypes that included 
high WC, while shorter stature was associated with higher likelihood of the OWOB only and 
OWOB+EBP phenotypes. Coefficients on household assets score were positive, and of 
similar size across all phenotypes, but precision of estimates varied with sample size such 
that not all comparisons were statistically significant. Higher household income was 
associated with OWOB phenotypes that included high WC. Pregnancies during survey 
intervals after 1998 were associated with higher risk of phenotypes that included high WC. 
Higher percentage of calories from protein (the omitted macronutrient in the model) were 
associated with increased likelihood of disease phenotypes that included high WC.
Compared to OWOB+high WC+healthy women, taller stature was associated with lower 
likelihood of OWOB+low WC, and of having EBP. Higher education was associated with 
increased likelihood of having EBP alone or in combination with diabetes. Higher 
percentage of calories from fat and carbohydrate were associated with an increased 
likelihood of the diabetes only phenotype (Supplemental table 4).
Given the well-established association of EBP with weight status, the normal weight+low 
WC+EBP phenotype is worthy of additional attention. This phenotype was one of the 4 most 
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prevalent in our sample and it increased substantially over time. Compared to the more 
typical pattern of EBP in overweight women with high WC, thin women with EBP were 
older, shorter, from households with lower income and assets, lived in less urbanized 
communities, and consumed total fewer calories, but a higher percentage of energy from fat. 
Reported blood pressure medication use in 2012 was less frequent in this phenotype (30.8% 
in 2012, 36.3% in 2015) compared to medication use in OW, high WC hypertensive women 
(47.0% in 2012, 52.1% in 2015).
Given the Philippines’ status as a low to middle income country, there is a remaining 
concern about undernutrition, particularly in older women. In 2015, 16.0% of women in the 
oldest age group had a BMI< 18.5, and among these underweight women, 35% were 
hypertensive. Fewer underweight hypertensive women were taking blood pressure 
medications (18.2% and 29.2% in 2012 and 2015 respectively) compared to 43.2% and 
51.9% of normal or OWOB hypertensive women.
Discussion
Our cohort of Filipino women followed through mid-life experienced large increases in 
OWOB, high WC, type 2 diabetes, and EBP prevalence, consistent with trends seen in other 
Southeast Asian countries. For example, based on national estimates, type 2 diabetes 
prevalence doubled in Vietnam between 2002 and 2012[26], and in Malaysia obesity 
prevalence increased from 12.2 in 2003 to 15.1% in 2011. [27]
The range of baseline participant ages in the CLHNS offered the opportunity to identify age 
and secular trends in these conditions. We found strong secular trends in all outcomes. Our 
youngest age group in 2015 was heavier and had more central adiposity and higher 
prevalence of EBP than the comparable age group in 2002. These changes reflect the rapid 
social and economic development in Metro Cebu in the past several decades. Similar 
increases have been observed in China, where the age-adjusted prevalence of BMI>24 
kg/m2 increased in women aged 40–59 from 31.6% to 50.6% from 1991–2011.[28] Higher 
BMI in younger aged women, and the noted secular trend in BMI is important in the context 
of public health, portending a worsening of CM disease risk and its associated health care 
costs and threats to quality of life if the trends are not reversed. Younger women who were 
of childbearing age through all survey years had larger increases OWOB prevalence 
compared to older women. In the oldest age group, OWOB prevalence changed very little, 
and some older women experienced weight loss during the past decade.
We identified phenotypes based on the co-occurrence of OWOB, high WC, diabetes and 
EBP. Healthy phenotypes did not persist. As women aged, most progressed out of healthy 
status, with the decline in healthy phenotypes largely reflecting sharp increases in EBP. 
Other longitudinal studies have also found that the metabolically healthy obese (MHO) 
phenotype is transient. For example, in the Korean Genome and Epidemiology study, hazard 
ratios for diabetes and CVD were moderately elevated (1.2 and 1.4, respectively), and about 
16% of individuals who were MHO at baseline had maintained that phenotype after 10 
years.[14] Similarly, in a US cohort, 20% of MHO individuals retained that phenotype after 
15 years.[12]
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OWOB, high WC, and diabetes were more likely among urban women with higher SES, 
marked by higher education, household assets and/or income. In contrast, EBP was more 
widely distributed. While most EBP was in women with OWOB and high WC, we also 
observed EBP in the absence of OWOB or high WC. This EBP-only phenotype increased 
from 8.5% in 1998 to 15.8% in 2015 and was more likely in older women residing in rural 
areas and having low income and assets. Across all years, 8.6% of women had BMI<18.5, 
but in the oldest age group, 16.1 % were underweight in 2015. The high level of EBP (35%) 
among underweight women in 2015, coupled with their lower use of anti-hypertensive 
medications calls attention to the need for better screening and health care in this group.
Stature significantly predicted some phenotypes. Stature represents women’s nutritional and 
socioeconomic history, and taller women are more likely to have higher SES and better 
nutritional status. Stature is also modestly correlated with WC (0.23), and significant height 
associations may partly reflect higher central adiposity not fully captured by our binary high 
WC variable.
We found only modest associations of phenotype with diet. Higher total energy was 
associated with OWOB, especially OWOB+high WC phenotypes. This is expected based on 
higher energy needs related to larger body size. Negative coefficients on percentage of 
calories from fat and carbohydrate indicate that a higher percentage of calories from protein 
(the omitted macronutrient category) was associated with higher likelihood of phenotypes 
associated with higher WC. In the Philippines, higher protein intakes largely reflect higher 
pork and fish consumption.
Additional biomarkers and more detailed body composition measures available in 2012 are 
informative for better understanding the phenotypes. Among normal weight+low WC 
women, those with diabetes or EBP had more central adiposity, even though WC was <80 
cm. Similarly, among OWOB women, those with diabetes or EBP had higher WC.
Filipino women are known to have a high prevalence of “isolated low HDL” compared to 
US and other populations.[29] The atherogenic ratio (TC/HDL) largely reflects low HDL in 
Cebu women, and is elevated with high WC. We used a BMI cut-point of 25 kg/m2 to define 
OWOB. If we used BMI>30, some relevant phenotypes had number too small for analysis. 
We chose the IDF cut-points for elevated blood pressure.[20] If we used obesity (>30) and 
the WHO definition of EBP, 5.3% of women would be classified as “healthy obese” in 2015 
(vs 20% with the definition we used).
Important limitations include attrition and missing data, the lack of directly comparable 
measures of diabetes across survey years, the change in blood pressure instrumentation 
between 2005 and 2012, and the lack of comparable lipid measurements and more detailed 
body composition data across all years. We completed a detailed analysis of attrition in the 
CLHNS, identifying causes of loss to follow-up across all years.[24, 25] Missing data were 
more likely in the earlier years of the study owing to exclusion of women when they were 
pregnant. Also of note is the increasing mortality related to diabetes and cardiovascular 
disease among older women. Since healthier individuals are more likely to survive into late 
ages, this will impact the apparent health profiles of the oldest cohorts through selection. 
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Selection related to survivorship may explain the lower diabetes prevalence among the oldest 
women in the sample (50+ years) compared to the remaining age groups. We restricted most 
of our analyses of diabetes to the 2005–2015 time period, when glycemic status was 
measured with biomarkers. We retained self-reported diabetes measures from 1998 and 2002 
in the multidimensional phenotype profiles, despite the likelihood of under-reporting in 
those years, so that we could have a longer time span over which to see change. We felt 
confident about this choice because a sensitivity analysis of correlates of self-reported vs 
biomarker-based diabetes status yielded no substantive differences.
Notable strengths of the study include long-term follow-up, with 5 surveys spanning 17 
years, and detailed data on important exposures and CM health related conditions, allowing 
us to differentiate phenotypes marked by different combinations of these conditions and to 
identify key predictors.
In sum, we noted strong age and secular trends in the prevalence of OWOB, high WC, 
diabetes and EBP associated with higher SES. While weight gain and CM disease 
prevalence were highest among higher income women, the burden of these diseases 
increasingly affected all income groups. The most frequent phenotype included concurrent 
OWOB, high WC and EBP. However, a sizeable subset of Cebu women had EBP despite 
having normal weight, or even despite being underweight. The healthy OWOB phenotype 
did not persist in most women. By 2015, when the mean age was 59 years, only 20% of 
CLHNS women had none of the 4 studied conditions. These data underscore the continuing 
need for public health measures in the Philippines to screen for CM diseases, and to provide 
guidance and treatment aimed at reducing weight gain and central adiposity while improving 
access to anti-hypertensive and other necessary medications.
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Age and secular trends in weight status (BMI>25 kg/m2), high waist circumference (>80 
cm), EBP (IDF definition) and diabetes in Filipino women, 1998–2015
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Phenotypes based on co-occurrence of overweight/obesity, (BMI>25 kg/m2), high waist 
circumference (>80 cm), EBP (IDF definition) and diabetes in Filipino women, 1998–2015
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